| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/28/2010 | EP2178871A2 Cyclic ethers |
| 04/28/2010 | EP2178868A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 04/28/2010 | EP2178375A1 Pyrazoloý1,5-a¨pyrimidine derivatives |
| 04/28/2010 | EP2178373A1 Heterocycles as potassium channel modulators |
| 04/28/2010 | EP1628980B1 6-arylmethyl-substituted pyrazolopyrimidines |
| 04/28/2010 | EP1463729B1 A process for producing phenserine and its analog |
| 04/28/2010 | CN1854137B Method for resoluting zopiclone |
| 04/28/2010 | CN1751041B 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN101698668A Crystal form V of Aildenafil citrate and preparation method and application thereof |
| 04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 04/27/2010 | US7705035 Indoline amide derivatives as EP4 receptor ligands |
| 04/27/2010 | US7705026 Biaryl heterocyclic compounds and methods of making and using the same |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7705004 Protein kinase inhibitors |
| 04/27/2010 | US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | US7704991 Substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/27/2010 | US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties |
| 04/27/2010 | CA2665543C Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2476494C Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2371816C Phthalamide-lanthanide complexes for use as luminescent markers |
| 04/22/2010 | WO2010045542A2 Fused ring heteroaryl kinase inhibitors |
| 04/22/2010 | WO2010045371A1 Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors |
| 04/22/2010 | WO2010045303A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 04/22/2010 | WO2010045276A2 Azabenzimidazolones |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010044885A2 Soluble mtor complexes and modulators thereof |
| 04/22/2010 | WO2010044485A1 Alpha helix mimetics in the treatment of cancer |
| 04/22/2010 | WO2010044470A1 Π-electron conjugated compound, manufacturing method therefor, and π-electron conjugated polymer obtained using same |
| 04/22/2010 | WO2010043880A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 04/22/2010 | WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90 |
| 04/22/2010 | WO2010043865A1 Inhibitors of hsp90 |
| 04/22/2010 | WO2010043676A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| 04/22/2010 | WO2010043633A1 2h-pyrazolo [4,3-d]pyrimidin-5-amine derivatives as h4 histamine receptor antagonists for the treatment of allergic, immunological and inflammatory diseases |
| 04/22/2010 | WO2010006130A3 Pde-10 inhibitors |
| 04/22/2010 | WO2010005528A3 Pyrrolopyridine carboxylic acid derivatives |
| 04/22/2010 | WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 04/22/2010 | WO2009151561A3 Methods and compounds for antimicrobial intervention |
| 04/22/2010 | US20100099730 Annellated pyrrole compounds for cancer management |
| 04/22/2010 | US20100099686 Compounds useful as protein kinase inhibitors |
| 04/22/2010 | US20100099679 FUSED BICYCLIC mTOR INHIBITORS |
| 04/22/2010 | US20100099561 Heterobicyclic alkylthio-bridged isoxazolines |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | CA2740885A1 Fused ring heteroaryl kinase inhibitors |
| 04/22/2010 | CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 04/22/2010 | CA2739148A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2735477A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 04/21/2010 | EP2177523A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/21/2010 | EP2176265A1 Imidazo [1, 2-c]pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists |
| 04/21/2010 | EP2176264A1 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 04/21/2010 | EP2176259A1 Fused imidazoles for cancer treatment |
| 04/21/2010 | EP2175859A1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| 04/21/2010 | EP2029602B1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1795195B Pyridopyrazines and the use thereof as kinase inhibitors |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN101696209A Diarylpyrazole [1,5-a] pyrimidine heterocyclic compound as well as preparation method and application thereof |
| 04/21/2010 | CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 04/21/2010 | CN101376109B Sodium-molybdenum series composite catalyst for synthesizing copper phthalocyanine |
| 04/20/2010 | USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 04/20/2010 | US7700768 such as 7-Methylsulfanyl-5-phenyl-1-(1-phenylethyl)-3,4-dihydro-1H -pyrimido[4,5-d]pyrimidin-2-one; p38 map kinase inhibitors |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides |
| 04/20/2010 | US7700606 Such as 8-[3-(2-Fluoropyridin-3-yl)phenyl]-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine; amyloid disorders, Alzheimer's disease, Down's syndrome |
| 04/20/2010 | US7700594 mammalian Target Of Rapamycin (mTOR) kinase; for treatment of lymphoma or ovarian cancer |
| 04/20/2010 | US7700587 Haloperidol analogs |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | CA2565411C Compounds and methods for inhibiting mitotic progression |
| 04/20/2010 | CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/20/2010 | CA2417001C Method for the manufacture of anagrelide |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2359964C Method for preparing bicyclic compounds and use of said method for preparing an interleukin-1-.beta. conversion enzyme (ice) inhibitor |
| 04/15/2010 | WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 04/15/2010 | WO2010042699A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 04/15/2010 | WO2010042684A1 Pyrrolotriazine kinase inhibitors |
| 04/15/2010 | WO2010042682A1 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 04/15/2010 | WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/15/2010 | WO2010042392A2 Hiv integrase inhibitors |
| 04/15/2010 | WO2010042391A2 Hiv integrase inhibitors |
| 04/15/2010 | WO2010041983A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | WO2010041194A1 Tricyclic oxazolidinone antibiotic compounds |
| 04/15/2010 | WO2010041108A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents |
| 04/15/2010 | WO2010040806A1 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors |
| 04/15/2010 | WO2010021717A3 Hcv protease inhibitors |
| 04/15/2010 | WO2010006086A3 Kinase inhibitors and methods of use |
| 04/15/2010 | WO2009143018A3 Pyrrolo [2, 3-d] pyrimidines as fm and kit kinase modulators |
| 04/15/2010 | WO2009048564A3 Modified colored pigments |
| 04/15/2010 | US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/15/2010 | US20100093997 Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors |
| 04/15/2010 | US20100093807 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions |